Bhat Bio-Tech India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.58 Cr
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.13 Cr
- Satisfied Charges ₹ 9.43 M
- Revenue Growth -71.62%
- Profit Growth -99.01%
- Ebitda -95.33%
- Net Worth 0.20%
- Total Assets -4.64%
About Bhat Bio-Tech India
Bhat Bio-Tech India Private Limited (BBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 March 1994 and has a history of 30 years and 11 months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.58 Cr.
The company currently has active open charges totaling ₹10.13 Cr. The company has closed loans amounting to ₹9.43 M, as per Ministry of Corporate Affairs (MCA) records.
Shama Bhat, Susheela Bhat, Kousalya Bhat, and Three other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33111KA1994PTC015346
- Company No.
015346
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Bhat Bio-Tech India Private Limited offer?
Bhat Bio-Tech India Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Corona Test Kit, Research and Development (R&D) Work, Product Development Research, Diagnostic Imaging & Pathology Labs, Medical Test Services, Sexual Wellness Products, Female Hygiene Products & Test Kits, Biochemistry Analyzer.
Who are the key members and board of directors at Bhat Bio-Tech India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pavan Kumar ![]() | Managing Director | 29-Sep-2017 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Susheela Bhat ![]() | Director | 03-Sep-1994 | Current |
Shama Bhat ![]() | Director | 09-Mar-1994 | Current |
Kousalya Bhat ![]() | Director | 30-Nov-1997 | Current |
Krishna Bhat ![]() | Director | 30-Nov-1997 | Current |
Shivarama Bhat ![]() | Director | 25-Aug-2001 | Current |
Financial Performance of Bhat Bio-Tech India.
Bhat Bio-Tech India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.62% decrease. The company also saw a substantial fall in profitability, with a 99.01% decrease in profit. The company's net worth moved up by a moderate rise of 0.2%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bhat Bio-Tech India?
In 2023, Bhat Bio-Tech India had a promoter holding of 79.82% and a public holding of 20.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹10.13 Cr
₹0.94 Cr
Charges Breakdown by Lending Institutions
- 3I Infotech Trusteeship Services Limited : 8.03 Cr
- Icici Bank Limited : 1.90 Cr
- Biotechnology Industry Research Assistance Council : 0.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
10 Oct 2012 | Biotechnology Industry Research Assistance Council | ₹2.00 M | Open |
22 May 2008 | 3I Infotech Trusteeship Services Limited | ₹8.03 Cr | Open |
06 Jan 2006 | Icici Bank Limited | ₹1.90 Cr | Open |
24 Jul 2012 | Biotechnology Industry Research Assistance Council | ₹9.43 M | Satisfied |
How Many Employees Work at Bhat Bio-Tech India?
Bhat Bio-Tech India has a workforce of 95 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bhat Bio-Tech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhat Bio-Tech India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.